At the UNC At the Center of Excellence for Eating Disorders, our mission is to better understand the causes and consequences of eating disorders in order to develop better treatment options. In pursuit of this mission, we conduct several research studies each year. To conduct these research studies, we need help from volunteers - individuals who want to help us better understand eating disorders. You can help by volunteering to join our research registry. Anyone can join our registry. We welcome volunteers with no history of an eating disorder, as well as volunteers with a current or past history of an eating disorder.

Are you or someone you know related to an adult or child with Type 1 Diabetes? If so, you may eligible to participate in TrialNet.

The participant registry will assist with study recruitment for current and future studies at the UNC-CH Adams School of Dentistry.

The purpose of this study is to establish a safe dose of study cells (ATLCAR.CD30.CCR4 and ATLCAR.CD30) to give to patients with CD30+ refractory/relapsed Hodgkin's Lymphoma and Cutaneous T-Cell Lymphoma.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.

We are looking for patients with kidney disease and healthy controls (no kidney disease) to provide blood samples, fill out surveys, and provide health related information to help investigators learn more about how to better diagnose and treat kidney disease. The information you provide will go into a "library" of data for doctors and researchers across the world to use for research projects. If you are a kidney patient, we are able to use your information to find out if you are eligible for treatment studies/other studies in the future.

Researchers are looking for current and former smokers with or without COPD to enroll in a registry to be contacted for future studies.

Do you have probable Dementia with Lewy Bodies (DLB), Mild Cognitive Impairment with "high likelihood" DLB, or Parkinson's Disease Dementia (PDD)? You may be able to participate in an observational study to track your disease progression and promote future research.

The purpose of this study is to establish a safe dose of study cells (ALTCAR.CD30) to give after chemotherapy and estimate progression free survival in pediatric patients with CD30+ refractory/relapsed Hodgkin lymphoma (HL) and non-Hodgkin lymphoma.